Navigation Links
AbbVie Reports Second-Quarter 2014 Financial Results
Date:7/25/2014

terests, by security holdings or otherwise, will be contained in the Proxy Statement/Prospectus when it is filed.

Forward-Looking Statements
This release contains certain forward-looking statements with respect to a combination involving AbbVie and Shire. The words "believe," "expect," "anticipate," "project" and similar expressions, among others, generally identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the possibility that necessary regulatory approvals or stockholder approvals will not be obtained or any of the other conditions to the combination will not be satisfied, adverse effects on the market price of AbbVie Shares and on AbbVie's or Shire's operating results because of a failure to complete the combination, failure to realise the expected benefits of the possible combination, negative effects relating to the announcement of the possible combination or any further announcements relating to the possible combination or the consummation of the possible combination on the market price of AbbVie shares or Shire shares, significant transaction costs and/or unknown liabilities, general economic and business conditions that affect the combined companies following the consummation of the possible combination, changes in global, political, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax laws, regulations, rates and policies, future business combinations or disposals and competitive developments. These forward-looking statements are based on numerous assumptions and assessments made in light of AbbVie's or, as the case may be, Shire's experience and perception of historical trends, current conditions, business strategies, operating environment, future development
'/>"/>

SOURCE AbbVie
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. AbbVie to Host Second-Quarter Earnings Conference Call
2. AbbVie to Host Fourth-Quarter and Full-Year 2013 Earnings Conference Call
3. AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C
4. AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy
5. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
6. Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
7. AbbVie Reports Third-Quarter 2013 Financial Results
8. AbbVie Named a Science Top Employer
9. AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
10. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
11. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Larry J. Merlo , President and CEO of CVS ... National Press Club in Washington, D.C. ... selling tobacco products and its leadership in driving the innovations ... changes in our health care system pose enormous challenges to ... "CVS Health has a truly unique combination of business assets ...
(Date:9/19/2014)... WALTHAM, Mass. , Sept. 19, 2014  Alere ... in rapid diagnostics, issued the following statement today in ... Combating Antibiotic-Resistant Bacteria. "As the global leader ... President for establishing a national strategy to address the ... continuing to work with the Administration on initiatives to ...
(Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... PLEASANTON, Calif., Dec. 2 Roche (SIX: RO, ROG; OTCQX: ... Administration (FDA) approved an additional intended use for its licensed ... of up to 96 individual donations. The test, called the ... s 201 system, is a qualitative, in-vitro test for ...
... , NANJING, China, Dec. 2 ... SCR ), a leading pharmaceutical company,specializing in ... pharmaceuticals in China, today reported that its,subsidiary Jiangsu Yanshen ... of all its products in order to conduct an,internal ...
Cached Medicine Technology:FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3
(Date:9/20/2014)... (PRWEB) September 21, 2014 Increases ... contributing to greater waste treatment volumes. However, government ... diverting waste from landfill. According to IBISWorld industry ... have implemented strategies aimed at reducing the volume ... waste recycled and recovered.” Still, a large proportion ...
(Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... Ariana Grande concert tickets. This popular ticket ... added savings. , Ariana Grande is nearing that next step ... is already considered a superstar in the music and entertainment ... who recently released her second straight No. 1 album, will ...
(Date:9/20/2014)... 20, 2014 As testosterone lawsuit ... federal court, Bernstein Liebhard LLP notes that advisors ... have voted overwhelmingly to recommend that prescription medications ... subjected to further study in order to investigate ... on September 18th by Bloomberg.com, the panel of ...
(Date:9/20/2014)... September 20, 2014 Lifeinsurancequoteterm.net has ... a no medical exam life insurance plan provides for ... vulnerable family members should be a top priority for ... life insurance without taking medical examinations and visiting a ... require medical examinations will provide coverage up to $300,000, ...
(Date:9/20/2014)... 20, 2014 (HealthDay News) -- As flu season approaches, ... is to get a flu shot and a checkup, ... primary care doctor can vaccinate people against the flu, ... may have. Retail stores may provide flu shots for ... said Dr. Jorge Parada, medical director of infection prevention ...
Breaking Medicine News(10 mins):Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:Get a Flu Shot During Checkup, Doctor Says 2
... , ... and his foundation to raise money to help the people of Haiti. It is Mr. Kent and ... ... Capital, LLC., and CEO of the Kent Marketing Group to join forces with former NFL player Jack ...
... ... April 1 – May 30, people age 65 and older can call to determine if they ... ... of change, but don’t worry if you don’t have the change to spare for an eye ...
... The American Academy ... wrinkles that become etched into the surface of the skin and don,t disappear once you,re ... the face and the pillow, allowing the delicate facial skin, to remain smooth for the ... ...
... ... MDX/American Registry Medical Patient,s Choice Award. , ... (Vocus) March 30, 2010 -- Five Summit Medical Group physicians ... Gruber, M.D., Jed A. Kwartler, M.D., Eric Mrisky, M.D., and Monib Zirvi, M.D., join ...
... ... Processes, an internationally recognized leader in literacy research, remediation, and professional development, will ... campaign beginning April 1st, 2010. , ... San Luis Obispo, CA (Vocus) -- Lindamood-Bell ...
... Global Initiative (BHGI) and the Latin American & Caribbean ... biennial BHGI Global Summit on International Breast Health June ... international organizations to address the optimization of breast health ... 2010 Summit is "Optimizing Health Care Delivery." ...
Cached Medicine News:Health News:Thomas J. Kent Jr. FDP Capital, LLC Chairman and Former NFL Player Jack Brewer Join Forces 2Health News:EyeCare America Ushers in the New Season and Springs for Eye Exams for Qualified Seniors 2Health News:EyeCare America Ushers in the New Season and Springs for Eye Exams for Qualified Seniors 3Health News:Mumbani™ Fresh Face Pillow, an Anti-Aging and Anti-Wrinkle Sleep Accessory for Side and Stomach Sleepers! 2Health News:Mumbani™ Fresh Face Pillow, an Anti-Aging and Anti-Wrinkle Sleep Accessory for Side and Stomach Sleepers! 3Health News:Summit Medical Group Physicians Receive Patients' Choice Award 2Health News:Summit Medical Group Physicians Receive Patients' Choice Award 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 2Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 4Health News:The Global Summit on International Breast Health 2
Standard vice clamp, can be fitted instead of Quick Realease Cassette...
... freezing stage is a refrigerated design for use ... for use with the 8000 sledge microtome, however, ... ,The refrigerated stage gives a large working area ... ridged to provide good adhesion between the specimen ...
... work, it is necessary to cool a specimen ... be fitted to most microtomes and will permit ... depending on conditions. The equipment consists of a ... stage is best suited for operation with a ...
... MNL 4404 & 4405 series Freezing Stages ... devices have no moving parts and need only ... water for operation. Freezing starts immediately ... is adjustable so that optimum cutting temperatures can ...
Medicine Products: